About Susmed
Cardio-metabolic care, delivered with a human pulse.
Susmed Life Science Pvt. Ltd. is an Indian pharmaceutical company building a focused portfolio across diabetes, cardiovascular risk, neuro support, bone and mineral care, gastro care and family wellness.
2023Incorporated
24Portfolio records
6Therapy areas
Science moves care forward — we make sure it reaches people who need it most.
Cardiovascular disease caused an estimated 19.8 million deaths in 2022. One global projection estimates that absolute cardiovascular prevalence could rise 90% between 2025 and 2050 as populations grow and age. Breakthrough therapies matter, but real-world impact depends on products, evidence and responsible access moving together.
Susmed connects focused therapies with the healthcare professionals, pharmacies and supply partners that turn scientific progress into day-to-day patient benefit.
01
Portfolio clarity
Curate focused therapy records around approved product material, reliable source documentation and responsible review.
02
Traceability-led supply
Strengthen distribution through documented hand-offs, clear pack information and accountable partner coordination.
03
Useful professional information
Help healthcare professionals and channel partners find current, clearly sourced information for confident, responsible conversations.
04
Access-minded growth
Consider affordability, availability and unmet need as the portfolio and partner network develop.
Built for India’s evolving chronic-care needs.
Connecting market insight with partner coordination.
Diabetes, cardio, neuro, bone & mineral, gastro and family wellness.
Figures describe global cardiovascular disease burden. The 2050 estimate concerns absolute prevalence and reflects population growth and ageing; age-standardised prevalence was projected to remain broadly stable.
Who we serve
Built around the people who move care forward.
Susmed connects therapy clarity, distribution discipline and practical support for the people who translate pharmaceutical science into everyday access.
One connected care pathway
Susmed access network
Useful information and responsible hand-offs become stronger when every participant can reach the right next step.
Healthcare professionals
Pack identification, source-labelled product records and a direct route for professional product queries.
Check pack, composition and source status in one place.
Why this matters
WHO's adherence framework emphasises that health systems and care teams must support patients over the long term; information alone is not enough.
WHO adherence reportPharmacists & distributors
Visible pack details, MRP, verification status and a focused path for availability or partnership enquiries.
Review pack facts before starting a supply conversation.
Why this matters
GDP frameworks place strong emphasis on correct storage, transport, traceability and recall procedures across medicine distribution.
EMA GDP overviewPatients & caregivers
Accessible therapy and product-identification information with clear prompts to seek advice from a qualified healthcare professional.
Understand the pack and know when to ask your doctor.
Why this matters
Caregiver-focused education can improve medication knowledge, confidence and preparedness, while evidence for broader clinical outcomes remains limited.
Systematic evidence reviewOur footprintOperating across Cuttack and Bengaluru, with digital enquiry pathways for healthcare and supply partners beyond those locations.
Susmed website information supports product identification and responsible enquiry routing. Approved prescribing information and independent clinical judgement remain the authoritative references for treatment decisions; verified company certifications are presented with supporting evidence.
Mission Pillars
Three promises. One disciplined way forward.
Science, access and partnership become meaningful only when visitors can see what each promise changes in practice.
Science
Keep every product conversation anchored to information visitors can identify and assess.
- Show the source and verification status of each product record.
- Publish confirmed pack facts through clearly source-labelled product records.
- Keep clinical decisions with qualified healthcare professionals and approved information.
Source statusVisible on product records
Evidence context
WHO identifies prevention, early detection and timely treatment through primary healthcare as essential parts of the response to noncommunicable diseases.
Read the WHO contextAccess
Make the route from pack discovery to a responsible enquiry clear, useful and transparent.
- Present pack, dosage form and MRP details where the source supports them.
- Organise products by therapy area, composition and practical need.
- Route availability and distribution questions through a focused enquiry path.
Pack clarityForm, MRP and source together
Evidence context
WHO guidance explains that storage and distribution controls protect medical products from risks across purchasing, storage, transport and distribution.
Review WHO distribution guidancePartnership
Build dependable relationships through relevant questions, accountable follow-up and clear boundaries.
- Capture organisation, location and area of interest before routing an enquiry.
- Issue a reference number so each website submission can be followed up.
- Create distinct pathways for professional, distribution and company conversations.
Focused follow-upReference-numbered enquiries
Evidence context
A systematic review found that bidirectional GP-pharmacist collaboration can improve several cardiovascular risk outcomes, while results vary by outcome and intervention.
View the systematic reviewThese pillars describe Susmed's website and relationship commitments. Verified operational capabilities, certifications and performance measures are published with their supporting company evidence.
Focused portfolio
Care areas organised for faster understanding.
Susmed presents its range as connected care pathways so professionals and partners can reach the relevant portfolio quickly.
Diabetes Care
Combination therapies across glimepiride, metformin, voglibose, DPP-4, and SGLT2 pathways.
Cardio Protection
Supportive products around vascular, lipid, and heart-risk conversations.
Neuro Support
Nerve health support products for neuropathy-focused care pathways.
Bone and Mineral
Calcium, vitamin, and mineral support for daily wellness and bone care.
Gastro Care
Gastro-protective combinations for acid reflux and dyspepsia support.
Family Wellness
Omega and antioxidant products for broader family health needs.
Why Susmed?
Principles that keep progress grounded.
Evidence before assertion
Use identifiable, current sources and approved wording before product information is published.
Clarity at every hand-off
Make pack, composition, form and source status easy for professional partners to understand.
Quality-led decisions
Treat documentation, review status and change control as part of everyday communication.
Regional insight
Build partner relationships around the needs of the markets and communities Susmed serves.
Responsible growth
Scale through verified milestones, clear ownership and evidence-led decisions.
Human partnership
Respect the experience of clinicians, pharmacists, distributors, regulators and the people behind care.
Built to execute responsibly
A focused company with a disciplined operating mindset.
Susmed combines regional insight with structured product governance. Every public product record presents its source status, professional boundary and review position with clarity.
Focused portfolio
A growing range organised around practical therapy needs rather than a flat product list.
Traceable information
Pack, composition and product imagery are connected to supplied label or catalogue evidence.
Partner-led access
Stockists, distributors, pharmacists and healthcare professionals can reach one accountable enquiry path.
Company incorporation
First Glimsus MV batch reaches pharmacies
Partner quality audit completed
Quality-management system development
Our pathway
From care need to accountable information.
Six connected steps keep product information useful, source-aware and easier to review at every hand-off.
One connected review sequence
- 01Understand the care need
- 02Review the evidence
- 03Verify the product record
- 04Apply quality governance
- 05Support responsible access
- 06Review and improve
Understand the care need
What happensOrganise therapy questions, product requests and partner input around the care areas Susmed serves.
Why it mattersStarting with a defined need helps the portfolio stay focused instead of becoming an undifferentiated catalogue.
Input: therapy and partner needs
Guidance context
WHO describes primary-healthcare action, early detection and timely treatment as important parts of the response to noncommunicable diseases.
WHO NCD contextReview the evidence
What happensCheck candidate product information against identifiable label, catalogue and public regulatory sources before publication.
Why it mattersSource screening keeps confirmed facts separate from details that still require company or label verification.
Gate: identifiable source material
Guidance context
WHO prequalification and regulatory guidance illustrate why quality, safety, efficacy and documented review matter when medical-product information is assessed.
WHO prequalification overviewVerify the product record
What happensConnect brand, composition, dosage form, pack views, MRP and source status in one structured website record.
Why it mattersConsistent fields make products easier to identify, search and update without implying regulatory-system integration.
Record: pack, form, MRP and source
Guidance context
ABDM materials describe a national Drug Registry vision with searchable approved-drug information. Susmed's website remains an independent company catalogue.
ABDM digital-health overviewApply quality governance
What happensUse named editors, review status, revision notes and authorised approval before controlled content becomes public.
Why it mattersClear ownership and documented decisions create a practical audit trail for corrections, updates and withdrawal.
Review: owner, status and revision
Guidance context
WHO quality-risk guidance stresses accessible documentation, structured knowledge management and periodic review of risk assessments.
WHO quality-risk guidanceSupport responsible access
What happensDirect product, professional and distribution questions through focused forms that capture role, location and purpose.
Why it mattersUseful context helps Susmed route enquiries responsibly while keeping website information within appropriate boundaries.
Route: role, market and purpose
Guidance context
WHO good storage and distribution guidance explains the responsibilities and controls that support quality across medicine supply chains.
WHO distribution guidanceReview and improve
What happensRetain dated revisions and revisit public information when source documents, product records or company decisions change.
Why it mattersA visible change history supports accurate updates, accountable review and continuous improvement.
Loop: dated revision and follow-up
Guidance context
WHO quality-risk guidance recommends reviewing risk assessments when appropriate and implementing additional controls when required.
WHO quality-risk guidance
Documentation & governance
Traceability from edit to public record.
The strongest quality story is one a visitor can understand and an authorised editor can reconstruct.
Every saved edit leaves a reviewable trail.
Susmed's website administration records who changed content, when it changed, which fields moved and why. Product approval status and recovery points add practical control without presenting the CMS as a regulatory e-dossier.
Visible source statusVerified and catalogue-sourced product records remain clearly distinguishable.Public product record
Named editor contextContent changes retain the editor account, display name and timestamp.Administration audit
Field-level change setBefore-and-after summaries identify what changed across a saved revision.Administration audit
Reason for changeRevision notes travel with content and product audit entries.Administration audit
Role-gated approvalOnly the main administrator can mark controlled product content approved.Product governance
Recovery pointsContent and product saves create restorable backups for the main administrator.Backup & restore
Revision anatomyWhat a recorded change contains
01Field updatedBefore and after summaries
02Editor and timeNamed account and UTC timestamp
03Review contextRevision ID and change note
Quality and compliance are communicated with evidence.
Public statements are organised by evidence status, while administrative changes retain review context. Current certificates and operational capabilities are presented with approved supporting evidence.
Standards context
WHO quality-risk guidance stresses structured documentation, accessible knowledge records and appropriate review. CDSCO distribution guidance also treats documentation and record keeping as important supply-chain controls. Verified company certifications are presented separately with their supporting evidence.
WHO quality-risk guidance CDSCO GDP guidance directory
100recovery points retained per content or product fileXLSfilterable audit-report exportROLErestricted product approval control
Susmed expands governance capabilities through staged technical validation, company approval and documented release controls.
Leadership Snapshot
Leadership with accountable direction.
Public corporate records identify the director below as part of Susmed Life Science Pvt Ltd from the company’s incorporation in April 2023.
Official portrait
Company leadership
Bhabani Sankar Das
Director · Appointed 30 April 2023Public corporate records identify Bhabani Sankar Das as a director of Susmed Life Science Pvt Ltd from its incorporation. His profile represents the company-level leadership responsible for guiding Susmed’s development as an Odisha-based pharmaceutical business and strengthening its portfolio and partner network.
View public company record
Connect with Susmed
Contact Susmed
Ready to start a focused conversation with Susmed?
Share your organisation, market and area of interest. Susmed will review the enquiry and route it to the appropriate business contact.